These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 15077679)

  • 1. In vitro efficacy of ganciclovir, cidofovir, penciclovir, foscarnet, idoxuridine, and acyclovir against feline herpesvirus type-1.
    Maggs DJ; Clarke HE
    Am J Vet Res; 2004 Apr; 65(4):399-403. PubMed ID: 15077679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro susceptibility of six isolates of equine herpesvirus 1 to acyclovir, ganciclovir, cidofovir, adefovir, PMEDAP and foscarnet.
    Garré B; van der Meulen K; Nugent J; Neyts J; Croubels S; De Backer P; Nauwynck H
    Vet Microbiol; 2007 May; 122(1-2):43-51. PubMed ID: 17276631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergy of bovine lactoferrin with the anti-cytomegalovirus drug cidofovir in vitro.
    van der Strate BW; De Boer FM; Bakker HI; Meijer DK; Molema G; Harmsen MC
    Antiviral Res; 2003 Apr; 58(2):159-65. PubMed ID: 12742576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel corneal explant model system to evaluate antiviral drugs against feline herpesvirus type 1 (FHV-1).
    Pennington MR; Fort MW; Ledbetter EC; Van de Walle GR
    J Gen Virol; 2016 Jun; 97(6):1414-1425. PubMed ID: 26959283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro comparison of antiviral drugs against feline herpesvirus 1.
    van der Meulen K; Garré B; Croubels S; Nauwynck H
    BMC Vet Res; 2006 Apr; 2():13. PubMed ID: 16640781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro antiviral drug sensitivity of the Kaposi's sarcoma-associated herpesvirus.
    Medveczky MM; Horvath E; Lund T; Medveczky PG
    AIDS; 1997 Sep; 11(11):1327-32. PubMed ID: 9302441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of susceptibility of human herpesvirus 8 to antiviral drugs by quantitative real-time PCR.
    Sergerie Y; Boivin G
    J Clin Microbiol; 2003 Aug; 41(8):3897-900. PubMed ID: 12904413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpesvirus resistance to antiviral drugs: a review of the mechanisms, clinical importance and therapeutic options.
    Reusser P
    J Hosp Infect; 1996 Aug; 33(4):235-48. PubMed ID: 8864937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro effects of antiviral agents on human keratocytes.
    Moreira LB; Oliveira C; Seitz B; LaBree L; McDonnell PJ
    Cornea; 2001 Jan; 20(1):69-72. PubMed ID: 11189008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro cytotoxicity and antiviral efficacy against feline herpesvirus type 1 of famciclovir and its metabolites.
    Groth AD; Contreras MT; Kado-Fong HK; Nguyen KQ; Thomasy SM; Maggs DJ
    Vet Ophthalmol; 2014 Jul; 17(4):268-74. PubMed ID: 24112415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral activities of nucleosides and nucleotides against wild-type and drug-resistant strains of murine cytomegalovirus.
    Smee DF; Barnett BB; Sidwell RW; Reist EJ; Holy A
    Antiviral Res; 1995 Jan; 26(1):1-9. PubMed ID: 7741517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of an acyclovir- and foscarnet-resistant herpes simplex virus type 1 lesion with intravenous cidofovir.
    LoPresti AE; Levine JF; Munk GB; Tai CY; Mendel DB
    Clin Infect Dis; 1998 Feb; 26(2):512-3. PubMed ID: 9502489
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro and in vivo inhibition of murine gamma herpesvirus 68 replication by selected antiviral agents.
    Neyts J; De Clercq E
    Antimicrob Agents Chemother; 1998 Jan; 42(1):170-2. PubMed ID: 9449280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy.
    Kedes DH; Ganem D
    J Clin Invest; 1997 May; 99(9):2082-6. PubMed ID: 9151779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a quantitative real-time TaqMan PCR assay for testing the susceptibility of feline herpesvirus-1 to antiviral compounds.
    Hussein IT; Field HJ
    J Virol Methods; 2008 Sep; 152(1-2):85-90. PubMed ID: 18597862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of antiviral efficacy against lymphotropic herpesviruses utilizing flow cytometry.
    Long MC; Bidanset DJ; Williams SL; Kushner NL; Kern ER
    Antiviral Res; 2003 Apr; 58(2):149-57. PubMed ID: 12742575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of human herpesvirus 6 to antiviral compounds by flow cytometry analysis.
    Manichanh C; Grenot P; Gautheret-Dejean A; Debré P; Huraux JM; Agut H
    Cytometry; 2000 Jun; 40(2):135-40. PubMed ID: 10805933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral drug susceptibility of human herpesvirus 8.
    Neyts J; De Clercq E
    Antimicrob Agents Chemother; 1997 Dec; 41(12):2754-6. PubMed ID: 9420052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cidofovir on cell death and replication of feline herpesvirus-1 in cultured feline corneal epithelial cells.
    Sandmeyer LS; Keller CB; Bienzle D
    Am J Vet Res; 2005 Feb; 66(2):217-22. PubMed ID: 15757118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recent advances in antiviral drugs--antiviral agents to HCMV, HHV-6, and HHV-7].
    Takahashi K
    Nihon Rinsho; 1998 Jan; 56(1):140-4. PubMed ID: 9465679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.